April 28, 2020
Ocular Therapeutix™ Announces Topline Results of Phase 3 Clinical Trial of DEXTENZA® for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
Data from Phase 3 clinical trial demonstrate statistically significant effect achieved at all pre-specified primary endpoints The Company intends to…